SOPHiA GENETICS SA
SOPH
$4.59
-$0.04-0.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.99% | 22.41% | 22.77% | 15.91% | 12.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.99% | 22.41% | 22.77% | 15.91% | 12.68% |
| Cost of Revenue | 24.56% | 24.58% | 26.08% | 20.29% | 3.67% |
| Gross Profit | 20.81% | 21.40% | 21.15% | 13.86% | 17.33% |
| SG&A Expenses | 17.97% | 20.15% | 24.05% | 25.19% | -3.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 138.79% | 432.56% | -266.67% | -33.33% |
| Total Operating Expenses | 15.25% | 14.42% | 19.57% | 19.48% | -2.08% |
| Operating Income | -7.78% | -6.31% | -16.27% | -23.24% | 14.50% |
| Income Before Tax | -12.95% | -34.60% | -5.85% | -44.04% | -26.10% |
| Income Tax Expenses | -49.70% | -164.12% | 393.85% | 373.29% | 59.18% |
| Earnings from Continuing Operations | -11.14% | -26.53% | -8.59% | -47.53% | -26.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.14% | -26.53% | -8.59% | -47.53% | -26.86% |
| EBIT | -7.78% | -6.31% | -16.27% | -23.24% | 14.50% |
| EBITDA | -7.70% | -6.80% | -18.98% | -27.01% | 14.03% |
| EPS Basic | -3.70% | -21.74% | -6.30% | -44.43% | -24.83% |
| Normalized Basic EPS | -5.41% | -29.73% | -3.65% | -41.05% | -24.04% |
| EPS Diluted | -3.70% | -21.74% | -6.30% | -44.43% | -24.83% |
| Normalized Diluted EPS | -5.41% | -29.73% | -3.65% | -41.05% | -24.04% |
| Average Basic Shares Outstanding | 7.16% | 3.93% | 2.12% | 2.13% | 1.65% |
| Average Diluted Shares Outstanding | 7.16% | 3.93% | 2.12% | 2.13% | 1.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |